亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Ototoxicity: a high risk to auditory function that needs to be monitored in drug development

耳毒性 听力损失 医学 听力学 人口 药品 药理学 内科学 环境卫生 化疗 顺铂
作者
Marie-Pierre Pasdelou,Lise Byelyayeva,Susanna Malmström,Sylvie Pucheu,M. Peytavy,Hugo Laullier,Donald B. Hodges,Abraham R. Tzafriri,Gaëlle Naert
出处
期刊:Frontiers in Molecular Neuroscience [Frontiers Media]
卷期号:17 被引量:6
标识
DOI:10.3389/fnmol.2024.1379743
摘要

Hearing loss constitutes a major global health concern impacting approximately 1.5 billion people worldwide. Its incidence is undergoing a substantial surge with some projecting that by 2050, a quarter of the global population will experience varying degrees of hearing deficiency. Environmental factors such as aging, exposure to loud noise, and the intake of ototoxic medications are implicated in the onset of acquired hearing loss. Ototoxicity resulting in inner ear damage is a leading cause of acquired hearing loss worldwide. This could be minimized or avoided by early testing of hearing functions in the preclinical phase of drug development. While the assessment of ototoxicity is well defined for drug candidates in the hearing field – required for drugs that are administered by the otic route and expected to reach the middle or inner ear during clinical use – ototoxicity testing is not required for all other therapeutic areas. Unfortunately, this has resulted in more than 200 ototoxic marketed medications. The aim of this publication is to raise awareness of drug-induced ototoxicity and to formulate some recommendations based on available guidelines and own experience. Ototoxicity testing programs should be adapted to the type of therapy, its indication (targeting the ear or part of other medications classes being potentially ototoxic), and the number of assets to test. For multiple molecules and/or multiple doses, screening options are available: in vitro (otic cell assays), ex vivo (cochlear explant), and in vivo (in zebrafish). In assessing the ototoxicity of a candidate drug, it is good practice to compare its ototoxicity to that of a well-known control drug of a similar class. Screening assays provide a streamlined and rapid method to know whether a drug is generally safe for inner ear structures. Mammalian animal models provide a more detailed characterization of drug ototoxicity, with a possibility to localize and quantify the damage using functional, behavioral, and morphological read-outs. Complementary histological measures are routinely conducted notably to quantify hair cells loss with cochleogram. Ototoxicity studies can be performed in rodents (mice, rats), guinea pigs and large species. However, in undertaking, or at the very least attempting, all preclinical investigations within the same species, is crucial. This encompasses starting with pharmacokinetics and pharmacology efficacy studies and extending through to toxicity studies. In life read-outs include Auditory Brainstem Response (ABR) and Distortion Product OtoAcoustic Emissions (DPOAE) measurements that assess the activity and integrity of sensory cells and the auditory nerve, reflecting sensorineural hearing loss. Accurate, reproducible, and high throughput ABR measures are fundamental to the quality and success of these preclinical trials. As in humans, in vivo otoscopic evaluations are routinely carried out to observe the tympanic membrane and auditory canal. This is often done to detect signs of inflammation. The cochlea is a tonotopic structure. Hair cell responsiveness is position and frequency dependent, with hair cells located close to the cochlea apex transducing low frequencies and those at the base transducing high frequencies. The cochleogram aims to quantify hair cells all along the cochlea and consequently determine hair cell loss related to specific frequencies. This measure is then correlated with the ABR & DPOAE results. Ototoxicity assessments evaluate the impact of drug candidates on the auditory and vestibular systems, de-risk hearing loss and balance disorders, define a safe dose, and optimize therapeutic benefits. These types of studies can be initiated during early development of a therapeutic solution, with ABR and otoscopic evaluations. Depending on the mechanism of action of the compound, studies can include DPOAE and cochleogram. Later in the development, a GLP (Good Laboratory Practice) ototoxicity study may be required based on otic related route of administration, target, or known potential otic toxicity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
21秒前
50秒前
1分钟前
1分钟前
YiWei完成签到 ,获得积分10
1分钟前
彩虹儿应助科研通管家采纳,获得10
1分钟前
好巧完成签到,获得积分10
1分钟前
万能图书馆应助嗨e采纳,获得10
2分钟前
3分钟前
江姜酱先生完成签到,获得积分10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
4分钟前
4分钟前
4分钟前
可爱的函函应助chongchong采纳,获得10
5分钟前
5分钟前
5分钟前
汉堡包应助科研通管家采纳,获得10
5分钟前
6分钟前
6分钟前
6分钟前
chongchong完成签到,获得积分10
6分钟前
chongchong发布了新的文献求助10
6分钟前
爱撒娇的大开完成签到 ,获得积分10
7分钟前
微笑襄完成签到 ,获得积分10
7分钟前
fengfenghao完成签到,获得积分10
8分钟前
8分钟前
Owen应助西安浴日光能赵炜采纳,获得10
9分钟前
风清扬应助AliEmbark采纳,获得10
9分钟前
AliEmbark完成签到,获得积分10
9分钟前
9分钟前
科研通AI2S应助科研通管家采纳,获得10
9分钟前
科研通AI2S应助科研通管家采纳,获得10
9分钟前
小瓶盖完成签到 ,获得积分10
10分钟前
10分钟前
10分钟前
10分钟前
10分钟前
Yunism发布了新的文献求助10
10分钟前
11分钟前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1500
Robot-supported joining of reinforcement textiles with one-sided sewing heads 800
含极性四面体硫代硫酸基团的非线性光学晶体的探索 500
Византийско-аланские отно- шения (VI–XII вв.) 500
Improvement of Fingering-Induced Pattern Collapse by Adjusting Chemical Mixing Procedure 500
水稻光合CO2浓缩机制的创建及其作用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4178038
求助须知:如何正确求助?哪些是违规求助? 3713457
关于积分的说明 11708130
捐赠科研通 3395192
什么是DOI,文献DOI怎么找? 1862753
邀请新用户注册赠送积分活动 921448
科研通“疑难数据库(出版商)”最低求助积分说明 833184